Mass spectrometry market to rise at 12.26% CAGR through 2028 | Healthcare Asia Magazine
, APAC
Photo from Envato

Mass spectrometry market to rise at 12.26% CAGR through 2028

Thanks to an increased investment in pharmaceutical and biopharmaceuticals.

The global market for mass spectrometry is projected to grow by $3.52b until 2028 at an estimated compound annual growth rate (CAGR) of over 12.26%, according to Technavio.

The sector is witnessing a notable expansion due to an increased investment in pharmaceuticals and biopharmaceuticals, driven by a focus on drug safety and a demand for precise diagnostic tools.

“Mass spectrometers play a crucial role in personalised medicine by screening biomarkers for disease phenotypes, enabling targeted drug development and individualised therapy,” the report said.

In line with this, key areas such as metabolomics and vaccine development are rising as research fields in the sector.

Moreover, new opportunities are growing in emerging countries and greenfield projects, requiring skilled professionals for method development and system operation.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!